Free Trial

Evoke (LON:EVOK) Shares Up 17.2% - Still a Buy?

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report) was up 17.2% on Wednesday . The company traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). Approximately 3,500,189 shares traded hands during trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a "buy" rating and set a GBX 140 ($1.83) target price on shares of Evoke in a report on Monday, December 16th.

Check Out Our Latest Report on EVOK

Evoke Stock Up 3.0 %

The stock has a market capitalization of £213.63 million, a P/E ratio of -1.20 and a beta of 0.84. The firm has a fifty day moving average price of GBX 62.59 and a two-hundred day moving average price of GBX 62.11.

Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Sell-side analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.

Insider Buying and Selling at Evoke

In other news, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the stock in a transaction dated Monday, March 31st. The shares were purchased at an average cost of GBX 48 ($0.63) per share, with a total value of £96,000 ($125,605.13). Also, insider Andrea Gisle Joosen acquired 14,572 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.92) per share, with a total value of £10,200.40 ($13,346.07). Company insiders own 27.00% of the company's stock.

Evoke Company Profile

(Get Free Report)

Read More

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines